Sign in
8-K

Current Report

Dianthus Therapeutics, Inc. /DE/ Filed Acc 0001193125-20-164669

Shareholder vote results

  • Item 5.07 Submission of matters to a vote of security holders

From the SEC's structured data for this filing

Loading d937695d8k.htm…